Download full report with analyst certification and important disclosures
Feb 29 2024, 07:10 GMT
The basis of the CRH investment case is not changing but it is accelerating. The company is delivering strong (and better-than-expected) earnings growth, higher margins, increased cash-flow and superior returns. This has created the headroom to invest in continued growth, especially welcome as it scales the integrated solutions strategy, and provide attractive shareholder returns. At the mid-point, we believe that the 2024 adjusted EBITDA guide is 5-6% ahead of expectations.
Feb 29 2024, 07:10 GMT